#VisualAbstract: Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to placebo in patients with ...
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to placebo in patients with ...
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to placebo in patients with Duchenne ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.